BBHC
NEXI

Brown Brothers Harriman & Co’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Brown Brothers Harriman & Co’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,915
Closed -$68K – 1544
2022
Q3 		$68K Hold
4,915
– – ﹤0.01% 677
2022
Q2 		$198K Hold
4,915
– – ﹤0.01% 466
2022
Q1 		$517K Buy
+4,915
New +$361K ﹤0.01% 338

Other funds holding NEXI

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Brown Brothers Harriman & Co's NEXI Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2022, closing a stake of 4,915 shares — an estimated $68K sold.

Brown Brothers Harriman & Co first reported a position in NEXI in Q1 2022 and held it in 3 quarters. The position peaked at $517K in Q1 2022. 29 funds tracked by Wall St. Rank hold NEXI as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining NexImmune, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 4,915 NexImmune, Inc. Common Stock shares in Q4 2022, an estimated $68K.
  • Brown Brothers Harriman & Co first reported a position in NexImmune, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's NexImmune, Inc. Common Stock position peaked at $517K in Q1 2022.
  • 29 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.